These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9045059)

  • 41. Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.
    Eichelbaum M; Spannbrucker N; Steincke B; Dengler HJ
    Eur J Clin Pharmacol; 1979 Sep; 16(3):183-7. PubMed ID: 499318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further analysis of sparteine oxidation in a Japanese population and comparison with data observed in different ethnic populations.
    Horai Y; Ishizaki T; Eichelbaum M; Hashimoto K; Chiba K; Dengler HJ
    Xenobiotica; 1988 Sep; 18(9):1077-84. PubMed ID: 3227705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: absence of evidence for deficient metabolizers.
    Arias TD; Jorge LF; Lee D; Barrantes R; Inaba T
    Clin Pharmacol Ther; 1988 Apr; 43(4):456-65. PubMed ID: 3356089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simple borohydride/GC method for measuring sparteine metabolites in man.
    Inaba T; Vinks A; Otton SV
    Br J Clin Pharmacol; 1986 May; 21(5):473-80. PubMed ID: 3718806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid determination of sparteine and its metabolites in urine.
    Veningerová M; Prachar V; Lukácsová M; Glasa J; Holomán J
    J Chromatogr; 1993 Dec; 622(2):274-7. PubMed ID: 8150877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 6 beta-hydroxycortisol excretion in relation to polymorphic N-oxidation of sparteine.
    Park BK; Eichelbaum M; Ohnhaus EE
    Br J Clin Pharmacol; 1982 May; 13(5):737-40. PubMed ID: 7082544
    [No Abstract]   [Full Text] [Related]  

  • 47. Are the traits for drug acetylation and oxidation co-inherited?
    Sardaş S; Karakaya AE; Idle JR
    Clin Genet; 1988 Aug; 34(2):143-4. PubMed ID: 3191610
    [No Abstract]   [Full Text] [Related]  

  • 48. Variability in the elimination of mianserin in elderly patients.
    Begg EJ; Sharman JR; Kidd JE; Sainsbury R; Clark DW
    Br J Clin Pharmacol; 1989 Apr; 27(4):445-51. PubMed ID: 2719901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on microbial transformation. XXVI. Microbial oxidation of (-)-sparteine.
    Furuya K; Aida K; Koiso Y; Okuda S
    Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):231-4. PubMed ID: 4711516
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetically determined variability in drug metabolism: dual slow acetylation and drug oxidation traits.
    Mahgoub A; Idle JR; Smith RL
    Lancet; 1979 Jul; 2(8134):154. PubMed ID: 88594
    [No Abstract]   [Full Text] [Related]  

  • 51. Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer.
    Idle JR; Mahgoub A; Sloan TP; Smith RL; Mbanefo CO; Bababunmi EA
    Cancer Lett; 1981 Feb; 11(4):331-8. PubMed ID: 7296526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with hyperthyreosis].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Forkasiewicz Z; Dawiskiba J; Bednarz W; Domosławski P
    Endokrynol Pol; 2006; 57(6):605-11. PubMed ID: 17253433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
    Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
    Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability in drug metabolism: importance of genetic constitution.
    Schellens JH; Breimer DD
    Pharm Weekbl Sci; 1987 Apr; 9(2):85-90. PubMed ID: 3295765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis].
    Milejski P; Orzechowska-Juzwenko K; Pawlik J; Kamienowski J; Horoch E; Niewiński P; Hurkacz M
    Neurol Neurochir Pol; 1996; 30(4):571-9. PubMed ID: 9045059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical significance of oxidation and acetylation genetic polymorphism in patients with Parkinson's disease].
    Milejski P; Orzechowska-Juzwenko K; Kamienowski J; Horoch E; Niewiński P; Hurkacz M; Rzemisławska Z
    Neurol Neurochir Pol; 1999; 33(5):1015-24. PubMed ID: 10672554
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.